Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Ardane Therapeutics Inc
Profile last edited on: 1/7/2024      CAGE: 5LBJ9      UEI: FZKMVBY8TGK6

Business Identifier: Neuroprotective drugs for glaucoma and cognition-enhancing drugs for autism
Year Founded
2009
First Award
2011
Latest Award
2011
Program Status
Inactive
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

1 Davol Square
Providence, RI 02903
   (401) 345-5979
   info@ardanetherapeutics.com
   www.ardanetherapeutics.com
Location: Single
Congr. District: 01
County: Providence

Public Profile

Ardane therapeutics is a biotech company developing neuroprotective drugs for glaucoma and cognition-enhancing drugs for autism

Extent of SBIR involvement

User Avatar
Phase I Awards
1
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$352,596
Phase II Dollars
$0
Total Awarded
$352,596

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2011 1 NIH $352,596
Project Title: Treatment Of Stroke Using A Novel Pdz Binding Peptidomimetic Drug

Key People / Management

  Andrew P Mallon -- President

  Elizabeth Garcia

Company News

There are no news available.